Willis Towers Watson plc Amnd 8.3
Source: RNS
Ap19
AMENDMENT
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
|
Name of person dealing (Note 1) |
J.P. Morgan Securities LLC |
|
Company dealt in |
Willis Towers Watson plc |
|
Class of relevant security to which the dealings being disclosed relate (Note 2) |
US$0.000304635 ordinary shares |
|
Date of dealing |
04 January 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
|
|
Long |
Short |
||||
|
|
Number |
|
(%) |
Number |
|
(%) |
|
(1) Relevant securities |
2,580,811 2.00 |
1,346,861 1.04 |
||||
|
(2) Derivatives (other than options) |
1,229,475 0.95 |
2,460,447 1.91 |
||||
|
(3) Options and agreements to purchase/sell |
|
|
||||
|
Total |
3,810,286 2.95 |
3,807,308 2.95 |
||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
|
Purchase/sale |
Number of relevant securities |
Price per unit (USD)
(Note 5) |
|
Sale (Borrow Return)
Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases
Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales |
19,500
46 38,507 30,000 66 600 554 37 100 193 107 100 33 2,646 18
1 655 300 881 5,000 1,230 3 2,000 30,000 15,786 1,574 3,609 200 300 99 100 29 600 4 4 3 8 104 100 100 10 200 1 18 200 1 3 500 100 16 1 38 100 121 34 25 100 2,646 40 48 100 1 408 100 118 100 |
N/A
203.6150 USD 203.7000 USD 203.9066 USD 204.0900 USD 205.3325 USD 205.4697 USD 205.5300 USD 205.6900 USD 205.7715 USD 205.7941 USD 205.8100 USD 208.5400 USD 208.6322 USD 210.6800 USD
203.6000 USD 203.6787 USD 203.6800 USD 203.7000 USD 203.7650 USD 203.8609 USD 203.8800 USD 203.8933 USD 203.9066 USD 203.9331 USD 203.9688 USD 203.9985 USD 204.0000 USD 204.0350 USD 204.0900 USD 204.1600 USD 204.1700 USD 205.3325 USD 205.9375 USD 206.3800 USD 206.5500 USD 207.2925 USD 207.7962 USD 207.9100 USD 207.9300 USD 208.0200 USD 208.0375 USD 208.0700 USD 208.1600 USD 208.1950 USD 208.2300 USD 208.2700 USD 208.2900 USD 208.3600 USD 208.4100 USD 208.4200 USD 208.4500 USD 208.4800 USD 208.5070 USD 208.5400 USD 208.5700 USD 208.5800 USD 208.6322 USD 208.6400 USD 208.6471 USD 208.7000 USD 208.7100 USD 208.7911 USD 210.4500 USD 210.6800 USD 211.7500 USD |
(b) Derivatives transactions (other than options transactions)
|
Product name, e.g. CFD |
Nature of transaction (Note 6) |
Number of relevant securities (Note 7) |
Price per unit (USD) (Note 5) |
|
Equity Swap |
Long Long
Short Short |
30,000 2,646
38,100 600 |
203.9056 USD 208.6322 USD
203.7000 USD 205.3325 USD |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
|
Product name, e.g. call option |
Writing, selling, purchasing, varying etc. |
Number of securities to which the option relates (Note 7) |
Exercise price |
Type, e.g. American, European etc. |
Expiry date |
Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
|
(ii) Exercising
|
Product name, e.g. call option |
Number of securities |
Exercise price per unit (Note 5) |
|
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
|
Nature of transaction (Note 8) |
Details |
Price per unit (if applicable) (Note 5) |
|
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and
any other person relating to the voting rights of any relevant securities under any option referred to
on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to
which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 attached? (Note 9) NO
|
Date of disclosure |
21 January 2021 |
|
Contact name |
Alwyn Basch |
|
Telephone number |
0207 742 7407 |
|
If a connected EFM, name of offeree/offeror with which connected |
N/A |
|
If a connected EFM, state nature of connection (Note 10) |
N/A |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
